Cell and Gene Therapy, SAB Insights
May 08, 2024
Cell and Gene Therapy, SAB Insights
May 01, 2024
RoslinCT Blog Series: Scientific Advisory Board Perspectives
Cell and Gene Therapy, SAB Insights
April 11, 2024
RoslinCT Blog Series: Scientific Advisory Board Perspectives
![[WEBINAR] iPSC cell line development and manufacture for cell therapies](https://www.roslinct.com/wp-content/uploads/2024/03/RoslinCT-iPSCs-Webinar.png)
Cell and Gene Therapy, Gene Editing, iPSC
March 15, 2024
[WEBINAR] iPSC cell line development and manufacture for cell therapies
Cell and Gene Therapy, Leadership
March 07, 2024
Governor Healey Highlights Life Sciences Investments from Mass Leads Act in Worcester and Hopkinton
Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing
December 11, 2023
RoslinCT to manufacture first-ever US FDA approved CRISPR-based gene therapy CASGEVY™ (exagamglogene autotemcel)
Cell and Gene Therapy, Leadership
December 07, 2023
Ian McCubbin receives Peter Dunnill award at bioProcessUK
Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing
November 28, 2023
RoslinCT to manufacture exagamglogene autotemcel (exa-cel) for Vertex Pharmaceuticals Inc following an extensive development collaboration
